Cargando…
Effects of teriparatide versus alendronate for treatment of postmenopausal osteoporosis: A meta-analysis of randomized controlled trials
OBJECTIVES: Osteoporosis remains a clinical challenge. Teriparatide is an anabolic drug and alendronate is an antiresorptive agent; both are used in the treatment of osteoporosis. Comprehensive reviews investigating the comparative safety and efficacy of teriparatide versus alendronate are scarce. T...
Autores principales: | Wang, Ya-Kang, Qin, Si-Qing, Ma, Tao, Song, Wei, Jiang, Ren-Qi, Guo, Jian-Bin, Li, Kun, Zhang, Yu-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457876/ https://www.ncbi.nlm.nih.gov/pubmed/28538396 http://dx.doi.org/10.1097/MD.0000000000006970 |
Ejemplares similares
-
The effects of teriparatide and bisphosphonates on new fractures in postmenopausal women with osteoporosis: A protocol for systematic review and meta-analysis
por: Ouyang, YuLong, et al.
Publicado: (2021) -
Efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: A systematic review and meta-analysis
por: Peng, Lihua, et al.
Publicado: (2017) -
Efficacy and safety of Xianling Gubao capsule in treating postmenopausal osteoporosis: A protocol for systematic review and meta-analysis
por: Lou, Fanglian, et al.
Publicado: (2021) -
Inflammation as a contributing factor among postmenopausal Saudi women with osteoporosis
por: Al-Daghri, Nasser M., et al.
Publicado: (2017) -
Association of osteoporosis risk and polymorphisms of osteoprotegerin gene T950C in postmenopausal Chinese women: A PRISMA-compliant meta-analysis
por: Xia, Yuansheng, et al.
Publicado: (2022)